BFA
IDIX

BlackRock Fund Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock Fund Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,378,059
Closed -$106M – 3933
2014
Q2 		$106M Sell
4,378,059
-274,787
-6% -$2.86M 0.03% 833
2014
Q1 		$28.1M Buy
4,652,846
+664,806
+17% +$4.64M 0.01% 1809
2013
Q4 		$23.8M Sell
3,988,040
-45,168
-1% -$209K 0.01% 1897
2013
Q3 		$20.9M Buy
4,033,208
+531,045
+15% +$2.33M 0.01% 1939
2013
Q2 		$12.6M Buy
+3,502,163
New +$14.3M ﹤0.01% 2132

BlackRock Fund Advisors's IDIX Position: Q3 2014 in Review

BlackRock Fund Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 4,378,059 shares — an estimated $106M sold.

BlackRock Fund Advisors first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $106M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock Fund Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 4,378,059 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $106M.
  • BlackRock Fund Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock Fund Advisors's IDENIX PHARMACEUTICALS INC position peaked at $106M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock Fund Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.